Top Markets
#1 Palladium Network Palladium Network +6.67%
#2 Victoria VR Victoria VR +4.08%
#3 Bridged NXPC Bridged NXPC +2.08%
#4 Tornado Cash Tornado Cash +2.06%
#5 龙虾 (Lobster) 龙虾 (Lobster) +1.72%
#6 aixbt by Virtuals aixbt by Virtuals +1.55%
#7 Prom Prom +1.52%
#8 SkyAI SkyAI +1.49%
#9 Wiki Cat Wiki Cat +1.14%
#10 Geodnet Geodnet +0.92%
Coin of the day
Palladium Network Palladium Network
Settings
Language
ENGLISH
Currency
USD
Theme
Rebus Holdings, Inc. Rebus Holdings, Inc.

Rebus Holdings, Inc.

RBSH
Rank in Stocks #42217
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for... Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was established in 2003 and maintains its headquarters in Westlake Village, California.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$3.21K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Rebus Holdings, Inc. (RBSH)

Category

Healthcare
Earnings for Rebus Holdings, Inc. (RBSH)
Earnings in 2026 TTM: 0
According to Rebus Holdings, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Rebus Holdings, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR